Chemoprophylaxis of Malaria Palliative

Palliative chemoprophylaxis of malaria (syn. clinical chemoprophylaxis of malaria) is a method of preventing relapses of malaria in patients in remission using antimalarial drugs.

Palliative chemoprophylaxis is prescribed after an attack of malaria to prevent relapse of the disease. It is carried out on an outpatient basis or in a hospital for 8 weeks after the symptoms of the acute period of the disease have subsided.

For palliative chemoprophylaxis, antimalarial drugs with a long half-life, such as chloroquine, mefloquine or primaquine, are used. The choice of a specific drug depends on the type of malaria pathogen and the sensitivity of the parasite to drugs in a given region.

Palliative chemoprophylaxis can reduce the frequency of malaria relapses and reduce the severity of subsequent attacks of the disease. However, it does not prevent malaria infection or provide lasting protection against the disease. To fully prevent malaria, it is recommended to combine palliative chemoprophylaxis with other measures such as the use of mosquito nets, repellents and vector control.

Malaria chemoprophylaxis is a method of preventing malaria that involves taking antimalarial drugs over several months or years. This method can be used to prevent malaria infection in people who are at risk, such as those with weakened immune systems or those living in areas with a high prevalence of malaria.

Palliative chemoprophylaxis is a form of chemoprophylaxis that is used to prevent malaria in patients with cancer. Patients receiving chemotherapy may be at risk of contracting malaria because chemotherapy can weaken immunity and increase the risk of infection.

For palliative chemoprophylaxis, the same drugs are used as for conventional chemoprophylaxis. However, the dose of the drug may be reduced to reduce side effects. In addition, palliative chemoprophylaxis can only be performed if the patient is in a stable condition and has no other serious illnesses.

It is important to note that palliative chemoprophylaxis does not replace conventional chemoprophylaxis and is not a replacement for cancer treatment. It only helps prevent malaria infection during chemotherapy.

Overall, malaria chemoprophylaxis is an important method of disease prevention and can be used to prevent infection in both healthy people and patients receiving chemotherapy.